Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors.

Tytuł:
Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors.
Autorzy:
Wang G; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China.
Fan M; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China.; School of Pharmacy, Guizhou Medical University, Guiyang, China.
Liu W; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China.; School of Pharmacy, Guizhou Medical University, Guiyang, China.
He M; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China.; School of Pharmacy, Guizhou Medical University, Guiyang, China.
Li Y; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China.
Peng Z; College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 1402-1410.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basingstoke, UK : Taylor & Francis, c2002-
MeSH Terms:
Antineoplastic Agents/*pharmacology
Naphthalenes/*chemistry
Sulfonamides/*pharmacology
Tubulin Modulators/*pharmacology
A549 Cells ; Antineoplastic Agents/chemistry ; Apoptosis/drug effects ; Cell Cycle/drug effects ; Cell Proliferation/drug effects ; Drug Screening Assays, Antitumor ; Humans ; MCF-7 Cells ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Structure-Activity Relationship ; Sulfonamides/chemistry ; Tubulin Modulators/chemistry
References:
Curr Med Chem. 2015;22(11):1348-60. (PMID: 25620094)
Clin Cancer Res. 2011 Aug 1;17(15):5152-60. (PMID: 21690571)
Med Res Rev. 2011 May;31(3):443-81. (PMID: 21381049)
Clin Cancer Res. 2004 Feb 15;10(4):1446-53. (PMID: 14977848)
Bioorg Chem. 2020 Nov;104:104265. (PMID: 32919128)
Nat Rev Drug Discov. 2010 Oct;9(10):790-803. (PMID: 20885410)
J Cell Biol. 2014 Aug 18;206(4):461-72. (PMID: 25135932)
Bioorg Med Chem Lett. 2010 Nov 1;20(21):6327-30. (PMID: 20850313)
Cancer Res. 2003 Oct 15;63(20):6942-7. (PMID: 14583495)
Mol Cancer Ther. 2014 Feb;13(2):275-84. (PMID: 24435445)
Nat Rev Cancer. 2004 Apr;4(4):253-65. (PMID: 15057285)
Curr Cancer Drug Targets. 2007 Sep;7(6):566-81. (PMID: 17896922)
Curr Med Chem. 2007;14(17):1829-52. (PMID: 17627520)
Pathol Biol (Paris). 2006 Mar;54(2):72-84. (PMID: 16545633)
Bioorg Med Chem. 2014 Jul 15;22(14):3620-8. (PMID: 24882676)
Nat Rev Mol Cell Biol. 2015 Dec;16(12):711-26. (PMID: 26562752)
J Med Chem. 2013 Oct 24;56(20):8008-18. (PMID: 24106982)
Bioorg Chem. 2018 Feb;76:249-257. (PMID: 29197743)
J Med Chem. 1992 Jun 26;35(13):2496-7. (PMID: 1619621)
Eur J Med Chem. 2018 May 10;151:482-494. (PMID: 29649743)
Eur J Med Chem. 2013 May;63:685-95. (PMID: 23567958)
Bioorg Chem. 2020 Jan;95:103565. (PMID: 31927336)
J Med Chem. 2006 Nov 16;49(23):6656-9. (PMID: 17154496)
Bioorg Chem. 2020 Oct;103:104141. (PMID: 32750611)
Eur J Med Chem. 2019 Dec 1;183:111731. (PMID: 31577977)
Lung Cancer. 2014 Aug;85(2):224-9. (PMID: 24888230)
Eur J Med Chem. 2019 Dec 1;183:111697. (PMID: 31536891)
J Enzyme Inhib Med Chem. 2020 Dec;35(1):139-144. (PMID: 31724435)
Expert Opin Ther Pat. 2019 Aug;29(8):623-641. (PMID: 31353978)
Contributed Indexing:
Keywords: Sulphonamide; anticancer activity; trimethoxyphenyl; tubulin polymerisation inhibitors
Substance Nomenclature:
0 (Antineoplastic Agents)
0 (Naphthalenes)
0 (Sulfonamides)
0 (Tubulin Modulators)
Entry Date(s):
Date Created: 20210623 Date Completed: 20210914 Latest Revision: 20210914
Update Code:
20240105
PubMed Central ID:
PMC8231400
DOI:
10.1080/14756366.2021.1943378
PMID:
34157927
Czasopismo naukowe
A new series of sulphonamide derivatives bearing naphthalene moiety were synthesised and evaluated for their antiproliferative and tubulin polymerisation inhibitory activities. These new compounds were evaluated for their in vitro antiproliferative activity against MCF-7 and A549 by using CCK-8 method. Among all the tested compounds, compound 5c with naphthalen-1-yl moiety exhibited the most potent antiproliferative activity against MCF-7 and A549 cell line, with IC 50 values of 0.51 ± 0.03 µM and 0.33 ± 0.01 µM, respectively. The results of tubulin polymerisation assay shown that 5c exhibited a significant ability to inhibit tubulin polymerisation with IC 50 value of 2.8 μM. Consistent with its antitubulin activity, 5c can significantly arrest the cell cycle at G2/M phase and induce apoptosis in MCF-7 cancer cells. Molecular docking study indicated that compound 5c inhibited tubulin polymerisation through interacting at the colchicine-binding site of tubulin. Furthermore, 5c exhibited low cytotoxic activity on human normal cell line.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies